Table 2.
Age at Onset (days) | Mutated Gene |
No Mutation | ||
---|---|---|---|---|
NPHS1a,b | NPHS2 | Otherc | ||
Proteinuria | ||||
0 to 7d | 47 | 8 | 1 | 11 |
8 to 30 | 12 | 5 | 2 | 6 |
31 to 60 | 4 | 4 | 1 | 4 |
61 to 90 | 0 | 3 | 2 | 1 |
NS | ||||
0 to 7d | 46 | 7 | 1 | 9 |
8 to 30 | 14 | 6 | 2 | 7 |
31 to 60 | 3 | 2 | 0 | 4 |
61 to 90 | 0 | 5 | 3 | 2 |
aOnly patients with two mutated NPHS1 alleles were considered for genotype–phenotype associations (n = 63).
bThree patients bearing one NPHS1 mutation and one single-nucleotide polymorphism in the compound heterozygous state presented proteinuria and NS during the first week of life (n = 2) and at 45 days after birth (n = 1). In addition, three patients with single heterozygous mutations in NPHS1 presented NS within the first week of life.
cIncludes patients with mutations in WT1, LAMB2, and PLCE1 and inherited mitochondrial disorders.
dPatients with NS detected in utero or stillbirths with CNS were considered to have a disease onset at day 0.